Upcoming Events
Hardware Training
Please contact Aneeka Hancock to sign up for a 2 hour training session:
Session 1: 9am-11am
Session 2: 11am-1pm
Session 3: 2pm-4pm
Contact:
Aneeka Hancock, Ph.D.
Phone: 1.415.278.1914
Email: Aneeka.Hancock@sartorius.com
Hardware & Forecyt Software Training
Please contact Aneeka Hancock to sign up for a 2 hour training session:
Session 1: 9am-11am Hardare Training
Session 3: 2pm-4pm Forecyt Software Training
Contact:
Aneeka Hancock, Ph.D.
Phone: 1.415.278.1914
Email: Aneeka.Hancock@sartorius.com
Workflow – Products – Technology – Protocols – Trouleshooting
Swing by with any workflow questions for current or upcoming projects, and inquiries on how MACS technology supports your cells. Looking forward to meeting you!
Learn about our on-site tissue dissociation and cell isolation instruments!
Alex Dudschus, Technical Sales Consultant (alexandradu@miltenyi.com)
Sample Preparation – Cell Separation – Cell Culture – Cell Analysis

Workflow – Products – Technology – Protocols – Trouleshooting
Swing by with any workflow questions for current or upcoming projects, and inquiries on how MACS technology supports your cells. Looking forward to meeting you!
Learn about our on-site tissue dissociation and cell isolation instruments!
Alex Dudschus, Technical Sales Consultant (alexandradu@miltenyi.com)
Sample Preparation – Cell Separation – Cell Culture – Cell Analysis

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
Join us for an exclusive Fundraising Salon organized by one of our residents, Charlie Silver from Ruby Bio, in support of the Leukemia and Lymphoma Society’s Light the Night; an event where community meets purpose. This event will feature lively dialogue from Dr. Rick Klausner, founder of Grail, Juno, Lyell and former Director of the National Cancer Institute, and Dr. Doug Crawford, founder of MBC BioLabs and Mission Bay Capital, as well as music from the East Bay Chamber Trio and food from local vendors. Thank you for your support!

MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.
MBC’s valued partner, Perkin Elmer Health Sciences (PKI), has transformed into Revvity (RVTY).
With “revolutionize” – rev – and “vita” (“life” in Latin) – vit – being rooted in our new name, Revvity represents commitment to revolutionizing human health at an accelerated speed, embracing the impossible to improve lives everywhere.
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, cell counting, screening, detection and diagnosis, informatics, and more.